In Re: Denosumab Patent Litigation - 1:25-md-03138

In Re: Denosumab Patent Litigation (Case No. 1:25-md-03138), filed on Feb 6, 2025 in the District Court, D. New Jersey involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:25-md-03138
Filing Date
Feb 6, 2025
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. New Jersey
Nature of Suit
Patent

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
AMGEN MANUFACTURING LIMITED LLC -
ACCORD BIOPHARMA, INC. -
CELLTRION, INC. -
FRESENIUS KABI USA, LLC. -
DENOSUMAB PATENT LITIGATION -
SAMSUNG BIOEPIS CO., LTD. -
INTAS PHARMACEUTICALS, LTD. -
Fresenius Kabi Austria GmbH -
HON. FREDA L. WOLFSON -
CELLTRION USA, INC. -
AMGEN, INC. -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

Docket entries not found - set an alert to get notified when docket entries are added.